Literature DB >> 7554134

Upregulation of cardiac angiotensin II AT1 receptors in congenital cardiomyopathic hamsters.

C Lambert1, Y Massillon, S Meloche.   

Abstract

Angiotensin II (Ang II) is a growth factor that stimulates protein synthesis and induces cellular hypertrophy in cardiac myocytes. To gain insight into the role of Ang II in cardiac hypertrophy, we examined the expression and subtype distribution of Ang II receptors in the ventricles of embryonic and of 25- to 350-day-old inbred control and cardiomyopathic (CHF 146) hamsters. Studies were also performed with heterozygous (cardiomyopathic x control) animals. Compared with the control hamsters, cardiomyopathic hamsters presented decreased body weights and increased ratios of ventricular weight to body weight in every adult group studied. Typical histological lesions appeared in the left ventricle of cardiomyopathic animals around 70 to 75 days, and their severity increased with time. Radioligand binding studies with cardiac ventricular membranes indicated that iodinated [Sar1,Ile8]Ang II (sarile) binds to a homogeneous population of sites in membranes derived from adult normal and cardiomyopathic animals. Competition curves using specific receptor subtype antagonists revealed that 125I-sarile binding sites were exclusively of the AT1 subtype in both groups of animals. Importantly, the density of AT1 receptors was found to be significantly increased (90% augmentation at 70 to 75 days) in the ventricles of cardiomyopathic hamsters. This augmented expression was observed in all adult groups and was already present at 25 days, when no histological lesions were visible. The affinity of the receptor for losartan did not vary significantly between adult normal and cardiomyopathic animals (mean Kd, 19.6 and 16.7 nmol/L, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554134     DOI: 10.1161/01.res.77.5.1001

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

Review 1.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

Review 2.  Cardiac GPCRs: GPCR signaling in healthy and failing hearts.

Authors:  Natasha C Salazar; Juhsien Chen; Howard A Rockman
Journal:  Biochim Biophys Acta       Date:  2007-02-20

3.  Effects of losartan on the collagen degradative enzymes in hypertrophic and congestive types of cardiomyopathic hamsters.

Authors:  K Masutomo; N Makino; M S Fushiki
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

4.  In vitro and in vivo effects of kinin B(1) and B(2) receptor agonists and antagonists in inbred control and cardiomyopathic hamsters.

Authors:  S Hallé; F Gobeil; J Ouellette; C Lambert; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction.

Authors:  Christiane Becari; Marcondes A B Silva; Marina T Durand; Cibele M Prado; Eduardo B Oliveira; Mauricio S Ribeiro; Helio C Salgado; Maria Cristina O Salgado; Rita C Tostes
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

6.  Modification of aortic contractility in the cardiomyopathic hamster.

Authors:  E C Dumont; C Lambert; D Lamontagne
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Protective effects of aspirin from cardiac hypertrophy and oxidative stress in cardiomyopathic hamsters.

Authors:  Rong Wu; David Yin; Nataliya Sadekova; Christian F Deschepper; Jacques de Champlain; Helene Girouard
Journal:  Oxid Med Cell Longev       Date:  2012-07-04       Impact factor: 6.543

8.  Angiotensin II (AT1) receptors and NADPH oxidase regulate Cl- current elicited by beta1 integrin stretch in rabbit ventricular myocytes.

Authors:  David M Browe; Clive M Baumgarten
Journal:  J Gen Physiol       Date:  2004-09       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.